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Tetracycline antibiotics, tetracycline, chlortetracycline, demeclocycline, doxycycline, minocy-
cline, methacycline, oxytetracycline, and anhydrotetracycline, are examined by electrospray
ionization in a quadrupole ion trap. Studies were undertaken to evaluate the use of metal
complexation as an alternative to conventional proton attachment. A variety of metal
cationization processes, including attachment of Na1, Mg21, Ca21, Co21, Ni21, and Cu21 were
probed. Infrared multiphoton photodissociation and collisionally activated dissociation (CAD)
were compared for generation of diagnostic fragmentation patterns of protonated and metal
cationized tetracyclines. The photodissociation spectra provide a more informative signature,
including more low mass ions that are not observed upon CAD. The metal complexes
dissociate by pathways that are similar to those observed for the protonated molecules. (J Am
Soc Mass Spectrom 1998, 9, 1089–1098) © 1998 American Society for Mass Spectrometry
Tetracyclines are the prototypical broad-spectrumantimicrobial drugs [1–3] (Figure 1). Tetracyclineantibiotics are bacteriostatic for a wide range of
gram-positive and gram-negative bacteria [4]. Interest
in the tetracycline structure increased when it was
discovered that as many as seven substituents could be
modified without diminution of biological activity,
which led to an intensified search for novel and more
effective modified tetracycline antibiotics produced
synthetically. The mode of action of the tetracyclines is
dependent on the presence of metal ions in solution.
Metal ions are believed to mediate binding of tetracy-
cline to macromolecular sites, to which they could not
bind by themselves [5]. The ability of tetracyclines to
bind metals has been proposed as a mechanism by
which transport through the cell membrane is facili-
tated by neutralizing the charge on the derivatives [6]. It
has also been observed that tetracyclines compete for
free metals in biological systems and excess metal ions
can neutralize the pharmacological action of tetracy-
clines [7], for example, when antacids containing cal-
cium or magnesium are administered with tetracycline.
Therapeutically active tetracyclines form dimers (2:1
ligand-to-metal complexes) with Cu21, Ni21, and Zn21,
whereas therapeutically inactive species form only
monomers (1:1 complexes) [8, 9]. Gastrointestinal ab-
sorption inhibition has been observed with tetracycline
binding to iron metal salts.
Investigators have attempted to establish the site or
sites of metal attachment [10–23]. Early work using
tetracycline derivatives and model compounds sug-
gested that oxygen coordination to the BCD-ring chro-
mophore permitted complex formation [10]. Spectro-
photometric work involving UV-vis absorption of
oxytetracycline as a function of pH [11] and circular
dichroism studies [12, 13] have determined that coordi-
nation sites involve both BCD- and A-ring chro-
mophores for a dipotassium salt adduct, but only the
A-ring chromophore for a mercuric chloride complex.
Based upon reflectance-IR spectra, A-ring coordination
has been proposed through oxygen atoms of the tricar-
bonylmethane chromophore [14]. Both proton [15, 16]
and 13C [17] NMR studies using para- and diamagnetic
metal ion complexes conducted in dimethyl sulfoxide
(DMSO) also confirmed that the primary location of
metal binding is ring A at the site of the tricarbonylm-
ethyl group, especially involving the oxygen donor
atoms. The binding site in tetracycline is highly pH
dependent [20] and conformational changes are ob-
served in aqueous media as a function of pH [12, 21–23].
In acidic environments, binding occurs at the O3 atom
on the A ring of the tetracycline. At neutral ranges,
tetracycline is deprotonated at the hydroxyl group at
the C12 position, and binding involves O10 and O12
oxygen donors via chelation. At alkaline ranges, bind-
ing may involve the dimethyl amino nitrogen along
with the O12a hydroxyl oxygen donor on the A ring,
and the tetracycline molecule is doubly deprotonated.
Binding constants measured for various tetracycline/
metal complexes indicate that complexation with cal-
cium or magnesium is most favored relative to other
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metals [8, 24, 25]. Calcium and magnesium are most
prevalent in vivo (calcium is present in 2.1 to 2.7 mM
and magnesium 0.75 to 1.1 mM) [26], so these two ions
are the most important in biological systems [27] (cal-
cium is 1013 times more concentrated in blood plasma
than copper). These previous studies have highlighted
the ability of tetracyclines to bind metals strongly, thus
providing evidence that metal ionization may be a
promising alternative to conventional proton attach-
ment for mass spectrometric analysis of this class of
molecules.
Previous mass spectrometric studies of tetracyclines
have included those that employed electron ionization
[28, 29], field desorption [30], liquid chromatography/
particle beam [31, 32], liquid chromatography/thermo-
spray [33], fast atom bombardment [34, 35], and elec-
trospray ionization (ESI) methods [34, 36, 37]. These
prior studies have focused on the quantitative determi-
nation of protonated tetracyclines, and studies of metal
complexation have not been reported.
The primary objective of the present work involves
the comparison of collisionally activated dissociation
(CAD) and infrared multiphoton photodissociation
(IRMPD) for generating diagnostic fragmentation pat-
terns of protonated and metal cationized tetracyclines.
The electrospray ionization mass spectra of eight tetra-
cyclines including tetracycline (TC), chlortetracycline
(CTC), demeclocycline (DMCTC), doxycycline (DC),
minocycline (MINO), methacycline (MTC), oxytetracy-
cline (OTC), and anhydrotetracycline (ATC) were ob-
tained (all but ATC are used medicinally). In addition,
studies were undertaken to evaluate the feasibility of
metal complexation with a variety of metals including
Na1, Mg21, Ca21, Co21, Ni21, and Cu21. The efficien-
cies of metal complexation versus protonation were
evaluated. In the present study, a model compound that
mimics the tricarbonylmethyl group on the A ring was
synthesized and its metal binding properties were com-
pared to TC [15].
Experimental
Experiments were performed using a Finnigan ion trap
mass spectrometer operating in the mass-selective in-
stability mode with modified electronics and isolated
endcaps to permit axial modulation. The needle tip was
placed 1–2 cm from the inlet aperture of the interface
flange. The interface, based on the design from Oak
Ridge [38, 39], was pumped to a pressure of 310 mtorr
using a 35 cfm Welch 1375 pump connected to four 12.7
mm pumping ports on the interface flange. To a con-
verted Finnigan 4000 vacuum chamber were connected
two turbomolecular pumps having a combined pump-
ing speed of 240 L/s for helium to attain a base pressure
of 5 3 1025 torr (corrected pressures using ionization
gauge). Helium was admitted to maintain a back-
ground pressure of 1 mtorr for CAD except when
IRMPD was being performed.
A positive voltage of 3–4 kV was applied to the
needle for positive ion mode, and ions were injected
through a 100-mm-diameter sampling orifice in A1,
typically maintained at 100–120 V. Lens elements
within the interface region (AL1 and AL2) were main-
tained at 30–90 V to optimize the ion signal. Aperture
plate A2 with a 350-mm exit orifice was held at ground
potential. Ions emanating from the exit aperture in A2
are focused through a seven-hole endcap into the ion
trap by applying suitable voltages to the elements in a
three lens system (L1, L2, and L3). Positive ions are
gated into the trap by inverting the gate voltage and
applying it to one of the half-plates comprising L2. At
all other times, ions were deflected away from the
entrance endcap. Typical injection times were 50–200
ms and ions were detected using a Channeltron 4773-G
(Galileo Electro-Optics, Sturbridge, MA) electron mul-
tiplier.
Tetracyclines were obtained from Sigma Chemical
(St. Louis, MO) and prepared in either methanol, ace-
tonitrile, 90:10 (v/v) methanol/water, 90:10 acetoni-
trile/methanol, or 90:10 acetonitrile/water in concen-
trations of 300 mM. Solutions containing the metals
(obtained as salts from Aldrich, Milwaukee, WI) were
600 mM in acetonitrile or methanol and were pumped
through a 12 in. section of Teflon tubing at the rate of
Figure 1. Structures of the tetracyclines.
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1–5 mL/min by a Harvard Apparatus 22 (Cambridge,
MA) syringe pump to a 120-mm-i.d. domed tip stainless
steel needle (SGE, Austin, TX) using zero dead-volume
fittings (Upchurch Scientific, Oak Harbor, WA) and
gas-tight syringe (Hamilton, Reno, NV).
Competitive metal attachment was performed by
adding to a 300 mM tetracycline solution a 600 mM
metal solution at a 1:1 v/v ratio to ensure that the metal
was in a 2:1 mole ratio to the analyte. Metals were
obtained from the salts of NaOH, MgCl2, CaCl2, CoBr2,
NiCl2, CuCl2 and precursor ions were isolated prior to
IRMPD or CAD by applying a stored waveform inverse
Fourier transform [40] isolation waveform of 6 Vp–p
[41]. Photodissociation was performed using a contin-
uous wave CO2 tunable laser (Apollo Laser Model 575,
Chatsworth CA) focused through a ZnSe window into a
6-mm hole drilled in the ring electrode. Exposure time
was controlled via a 5 V TTL pulse to a shutter control
box (Vincent Associates, Uniblitz Model 2000, Auburn,
CA) operating the mechanical shutter [42]. Pressure
during IRMPD was maintained at 3 3 1025 torr to
reduce collisional deactivation, whereas pressure dur-
ing CAD was maintained at 1 3 1023 torr. Typical
irradiance was 20–30 W for 5–400 ms.
Synthesis of the model compound, 2-car-
bamoyldimedone (2-carbamoyl-5,5-dimethylcyclohex-
ane-1,3-dione) was carried out according to the proce-
dure of Scarborough and Gould [43]. A solution of 300
mM 2-carbamoyldimedone in methanol was prepared
for the ESI mass spectrometric study.
Results and Discussion
Ionization by Protonation Versus Metal
Attachment
The competition between metal and proton binding of a
ligand is essential in determining the strength of the
metal–ligand binding interaction. Tetracyclines contain
electron-rich nucleophilic groups such as amines and
carbonyls, and therefore can be expected to bind metals
in neutral or mildly acidic solutions, but not in highly
acidic solutions, where the normal sites of metal attach-
ment are preferentially bound to protons. A variety of
solution pH ranges, salt concentrations, and other elec-
trospray variables were optimized in order to maximize
signal intensity obtained for protonation versus metal
complexation. In conditions inherent to the electrospray
process, solvent molecules surrounding the tetracycline
that normally improve stability of metal complexes are
minimized as solvent molecules are shed because of
desolvation in the interface region and in the trap. Thus,
metal attachment at some locations on the tetracycline
molecule observed by ESI mass spectrometry may be
significantly less favorable than at those binding sites
predicted based on a solution model.
In solution, metal attachment may occur at one of
several sites [10–23, 44, 45], including the C10–C11
phenolic diketone system and the C1–C3 tricarbonyl-
methane moiety, as discussed above. Based on the
gas-phase basicities of numerous reference compounds
that mimic regions of the tetracyclines, the expected site
of protonation for the tetracyclines in the gas phase is
the C4 dimethyl amino nitrogen or the C2 amide
nitrogen. In fact, for all of the tetracyclines (except for
minocycline), abundant protonated ions dominate the
ESI spectrum. For MINO in acidic solutions, doubly
charged species occur as the predominant ion. The sites
of proton attachment for MINO are expected to be the
C7 dimethylamine and either the C2 amide nitrogen or
the C4 dimethylamine. No other tetracycline but MINO
was observed to exhibit intense double protonation,
thus giving strong evidence that the second site of
protonation must be the C7 dimethylamine nitrogen.
To produce metal complexes, the metal salts were
dissolved in the tetracycline solutions, and the resulting
mixtures were sprayed. Regardless of the spray, inter-
face, or trapping conditions, the most abundant com-
plexes for the alkaline earth metal and transition metal
experiments were complexes that incorporated the dou-
bly charged metal ion and two, or to a lesser extent
three, solvent molecules. An example is shown in
Figure 2 for the solution containing tetracycline and
CoBr2 in acetonitrile. Only the singly charged alkali
metal complexes retained no solvent molecules. This
strong coordination of the solvent molecules by the
alkaline earth and transition metal ions is not com-
pletely surprising because the ESI spectra of solutions
containing only the metal ions in methanol or acetoni-
trile show dominant cluster formation of the type
M21(S)n where M is the metal ion and S are solvent
molecules. For the doubly charged metal ions, n is
typically four or five, and these clusters are evidently
extremely stable in the ion trap. Based on the observed
formation of the (TC1M2112S) and (TC1M2113S)
complexes in the present study, it appears that the
tetracycline molecule replaces two coordination sites
occupied by solvent molecules, thus allowing the metal
ion to maintain the same coordination sphere. This
result suggests that the tetracycline molecule chelates
Figure 2. ESI spectrum of a solution containing tetracycline and
CoBr2 in acetonitrile.
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the metal ion through two cooperative interactions, a
feature rationalized based on the well-known binding
properties of this class of molecule.
To further probe the site of metal attachment, a
model compound, 2-carbamoyldimedone (Figure 3)
was synthesized for electrospray studies. 2-Car-
bamoyldimedone mimics the A-ring tricarbonylmeth-
ane functionality and has been used previously for
metal complexation NMR studies. In the present ESI
studies, 2-carbamoyldimedone undergoes ready depro-
tonation (because of the great acidity of the hydroxyl
group) in conjunction with metal complexation, thus
resulting in singly charged metal complexes. Because
these complexes are singly charged, they do not allow
conclusive comparison to the tetracycline complexes,
and thus the binding site could not be confirmed in
greater detail. However, the singly charged metal com-
plexes typically incorporate two or three solvent mole-
cules, similar to that observed for the tetracycline metal
complexes.
For the electrospray experiments reported here, pro-
ton attachment always generates greater ion signal
intensity than any type of metal complexation when
conditions are optimized for each ionization process
(see Figure 4). Complexation with Mg21 ions produces
the greatest ion signal intensity of all the metals,
whereas complexation with alkali metal ions produces
relatively low signal intensity. Thus, although the tet-
racyclines are known to strongly bind metal ions in
solution, there is no observed signal enhancement for
metal complexation in ESI. Although protonation ap-
pears to be about three to five times more efficient than
alkaline earth metal complexation or transition metal
complexation, the metal complexes are still sufficiently
abundant for further structural characterization with
the possibility that the reduction in precursor signal
intensity may be offset by improved diagnostic merit of
the fragmentation patterns of the metal complexes
relative to those of the protonated tetracyclines.
Collisionally Activated Dissociation of Protonated
Tetracyclines
Although the fragmentation patterns of protonated
tetracyclines have been reported previously [31–36], we
examined the CAD spectra in the quadrupole ion trap
to provide reference spectra for comparison to the
IRMPD spectra of the protonated molecules and to the
CAD spectra of the metal complexes. An example is
shown for tetracycline in Figure 5. The results for the
other tetracycline compounds are summarized in Table
1. In general, the CAD patterns show an array of
fragment ions that are identified as characteristic of the
whole class of molecules. For example, common frag-
ments include ions at m/z 154, 126, 98, and 58.
Possible structures for these common fragment ions are
shown in Scheme 1, but numerous other resonance
structures and other isomers could be proposed. All of
these fragment ions incorporate a portion of the A ring
and are rich in oxygen and/or nitrogen atoms. MS/
MS/MS studies were undertaken to further probe the
genealogy of the fragment ions at m/z 154, 126, and 98.
After isolation and collisional activation, the fragment
ion at m/z 154 dissociated predominantly to m/z 126
and 98 (Figure 6) with other minor fragment ions at
m/z 86, 70, 68, and 58, thus confirming that some
portion of the fragments at m/z 98 and m/z 126 stem
from the m/z 154 ion. MS/MS/MS of m/z 126 leads to
formation of m/z 98, and the fragment ion at m/z 98
dissociates to ions at m/z 80 (via loss of water) and m/z
68 and 70. Based on these MS/MS/MS experiments, the
structures proposed in Scheme 1 were designed to
maintain reasonable fragmentation pathways from m/z
154 to m/z 126 to m/z 98 via losses of CO units. For the
Figure 3. Structure of model: 2-carbamoyldimedone.
Figure 4. Relative ionization efficiencies for alternative ioniza-
tion processes.
Figure 5. CAD spectrum of protonated tetracycline.
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two main structures proposed for m/z 154, one has the
formula C7H8NO3 (A), whereas the other has the for-
mula C8H12NO2 (B). These elemental compositions
could not be distinguished with the nominal resolution
of our ion trap mass spectrometer, and both types of
proposed structures seem reasonably consistent with
Table 1. (continued)
Fragment ion Neutral loss CAD IRMPD
3651 7 5
3351 7 9
2391 2 2
2261 7 4
2081 0 6
2011 10 13
1541 6 14
1261 8 1
981 2 1
861 0 2
581 0 6
Oxytetracycline
4441 NH3 5 0
4431 H2O 20 2
4261 H2O, NH3 51 9
4081 2H2O, NH3 4 9
3991 2 0
3811 2 1
3651 1 3
3501 0 1
3371 8 3
2821 0 5
2681 0 6
2081 0 4
2011 2 11
1541 5 27
1261 0 2
981 0 3
861 0 6
581 0 8
Anhydrotetracycline
4101 NH3 69 60
3211 2 2
2691 3 2
1541 22 31
981 4 2
581 0 3
Table 1. CAD and IRMPD spectra of protonated compounds:
Percentage of fragment ions
Fragment ion Neutral loss CAD IRMPD
Tetracycline
4281 NH3 7 3
4271 H2O 13 5
4101 H2O, NH3 41 7
3921 2H2O, NH3 7 3
1701 0 2
1541 20 41
1261 0 15
981 12 16
861 0 4
581 0 4
Doxycycline
4281 NH3 58 23
4101 NH3, H2O 6 5
3921 NH3, 2H2O 0 2
3491 0 2
3391 3 1
3211 11 3
3031 0 3
2941 3 4
2661 2 5
2511 0 3
1541 10 24
1261 2 12
981 5 5
861 0 2
581 0 6
Minocycline
4411 NH3 39 15
4231 NH3, H2O 0 3
3521 17 5
3371 15 19
2831 11 3
2681 3 0
2211 6 0
2161 2 0
1541 7 17
1261 0 5
981 0 14
861 0 5
581 0 14
Chlortetracycline
4641 NH3 3 1
4631 H2O 13 5
4461 H2O, NH3 30 41
1541 40 40
1261 2 3
981 12 5
861 0 3
581 0 2
Demeclocycline
4491 NH3 45 3
4311 NH3, H2O 21 4
2891 9 8
2611 2 3
1541 19 51
1261 2 4
981 2 23
721 0 1
581 0 3
Methacycline
4261 NH3 44 32
3811 7 6
Scheme 1. Possible structures of fragment ions.
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the MS/MS/MS patterns and the original precursor
structure of tetracycline.
In addition to the characteristic series of fragment
ions at m/z 154, 126, 98, and 58, the protonated
tetracyclines typically lose water, ammonia, or a com-
bination of both, as noted previously [31–36]. Five out
of the eight tetracyclines, including DC, DMCTC, MTC,
ATC, and MINO, undergo loss of ammonia instead of
dehydration, whereas the other three may undergo
dehydration first [31–34]. The three that undergo dehy-
dration, TC, OTC, and CTC, have the common feature
that they possess a hydroxyl group at the C6 position,
whereas the others do not. Although the C6 hydroxyl
group is not the most basic site in the molecule and
would not be expected to be the thermodynamically
favored site of protonation, the proton may migrate
from a more basic amine site to the C6 hydroxyl group
during collisional activation, thus promoting dehydra-
tion. The electron-donating, charge stabilizing ability of
a methyl group may permit stabilization of the carbo-
nium ion that would form if dehydration specifically
involved the C6 hydroxyl group.
MS/MS/MS experiments undertaken on some of the
higher mass fragment ions observed in the CAD spectra
(i.e., the ions stemming from loss of water and/or
ammonia) confirm that the high mass ions dissociate to
the same common lower mass fragment ions, namely
m/z 154, 126, and 98. For example, protonated anhy-
drotetracycline dissociates predominantly by loss of
NH3, resulting in the fragment ion at m/z 410 (Table 1).
The ion at m/z 410 was subsequently isolated and
activated, resulting in the MS/MS/MS spectrum in
Figure 7. The two dominant fragment ions are 981 and
1541, confirming that the deaminated anhydrotetracy-
cline ion may undergo the same types of fragmentation
processes as protonated anhydrotetracycline.
Photodissociation of Protonated Tetracyclines
Fragmentation patterns obtained using conventional
CAD in the ion trap often results in discrimination of
the low mass fragment ions because of the low mass cut
off established by the rf voltage during activation.
Because the low mass cut off influences the energy
deposition and ability to trap fragment ions, extremely
low values cannot be used successfully with CAD
experiments because the high mass precursor ions will
not be efficiently activated prior to ejection. To circum-
vent this limitation, the use of photodissociation to
obtain fragmentation patterns of ions provides a prom-
ising alternative [42]. In addition, ejection of fragment
ions because of collisional scattering is minimized upon
photoactivation because kinetic energy is not imparted
to the ions, whereas an increase in the ion kinetic energy
is the first step of the CAD process, thus unavoidably
leading to more ion scattering. Moreover, tedious tun-
ing of the activation process is unnecessary in photo-
dissociation because it is a nonresonant process.
The infrared photodissociation spectra acquired for
the protonated tetracyclines are summarized in Table 1.
Although many of the fragment ions observed for
photodissociation versus collisional activated dissocia-
tion are the same, there are additional fragment ions
seen in the photodissociation spectra, especially ones
appearing in the mid to lower mass range. In many
cases, the photodissociation spectra provide a greater
array of fragment ions that might be useful for selected
reaction monitoring or pattern recognition methods. A
comparison of the photodissociation (A) versus CAD
spectra (B) for protonated doxycycline in Figure 8
illustrates the enhancement of low mass fragment ions
by the photoactivation method.
Most of the protonated tetracycline molecules also
form a few types of mid mass fragment ions that are
characteristic for each individual compound. The iden-
tities of these fragment ions are more difficult to assess
because they are unique to each compound and thus do
not contain common skeletal features. For example,
protonated doxycycline dissociates to mid mass ions at
m/z 266, 303, 321, and 339. We have proposed a
possible fragmentation scheme for one of the com-
pounds, protonated doxycycline, in Scheme 2. In most
cases, these fragment ions were not sufficiently abun-
dant to allow informative MS/MS/MS experiments, so
their identities remain speculative.
In general, the IRMPD spectra show a greater por-
tion of the diagnostic lower mass ions at m/z 58, 86,
98, 126, and 154, and thus a lower amount of the simple
dehydration/deamination fragment ions at high mass.
We speculate that the lower mass fragment ions are
favored in the IRMPD spectra because the photoabsorp-
tion process is nonselective, meaning that the high mass
fragment ions may undergo photoabsorption during
the activation interval, thus decomposing further to the
lower mass ions. In the CAD experiment, the high mass
fragment ions are off-resonance from the activation
Figure 6. CAD spectrum of 1541 (MS/MS/MS) from protonated
tetracycline.
Figure 7. CAD spectrum of the (M1H1 2 NH3) ion from
protonated anhydrotetracycline.
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voltage, so they are not energized after their formation
and remain as stable ions in the trap (unless those high
mass fragment ions are specifically activated during
subsequent MS/MS/MS experiments). As mentioned
earlier, MS/MS/MS experiments for the higher mass
fragment ions observed in the CAD spectra directly
show that the high mass ions efficiently dissociate to the
lower mass fragment ions, m/z 154, 126, and 98,
confirming that the IRMPD process may lead to effi-
cient energization and dissociation of the higher mass
fragment ions. The photodissociation method is easily
tunable by varying the exposure time, thus allowing
some modification of the extent of fragmentation. Be-
cause the sequence of ions at m/z 58, 86, 98, 126, and
154 provides the signature for the whole class of tetra-
cyclines, these ions would be more useful when screen-
ing mixtures for the presence of any type of tetracycline.
A lower exposure time would allow enhancement of the
higher mass fragments which would be preferable
when trying to distinguish the specific identities of
different tetracyclines.
Photodissociation and Collisionally Activated
Dissociation of Metal Complexes
Because metal complexation of the tetracyclines proved
to be a moderately successful alternative to protonation,
the fragmentation patterns of the metal complexes were
evaluated for their diagnostic utility. As discussed
above, the dominant metal complexes involving the
alkaline earth or transition metals incorporated two
solvent molecules, so these were the complexes that
were isolated for subsequent activation experiments.
Experimental efforts were focused on an extensive
examination of tetracycline rather than each of the
derivatives, and examples are shown in Figures 9 and
10 for the CAD and photodissociation of (tetracycline1
Co2112CH3CN) and for the photodissociation of (tetra-
Figure 8. Photodissociation (A) and collisionally activated disso-
ciation (B) spectra of protonated doxycycline.
Scheme 2. Proposed fragmentation scheme for protonated doxy-
cycline.
Figure 9. (A) Photodissociation spectrum of (tetracycline1Co211
2CH3CN) complex. (B) Expanded region.
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cycline1 Na1) in Figure 11A. The results are summa-
rized in Table 2.
In general, the fragmentation patterns of the metal
cationized complexes afford equivalent or less informa-
tion than those of the protonated species. For the metal
cationized species shown in Table 2, many of the
neutral losses can be identified as elimination of solvent
molecules, or in some cases losses of solvent molecules
in conjunction with water or ammonia. In addition,
many of the lower mass ions are the same ones seen in
the CAD or IRMPD spectra of protonated tetracycline,
indicating that the metal ion is lost during these frag-
mentation processes.
The CAD spectrum of (tetracycline1Na1) predomi-
nantly undergoes loss of ammonia or loss of ammonia
and water, and no structurally informative ions of
lower mass are seen under any CAD conditions (see
Figure 11A). Interestingly, the observation of these
fragmentation pathways confirms that the loss of am-
monia and the subsequent loss of water involve in-
tramolecular hydrogen migration that are not initiated
by the addition of a proton. Moreover, the CAD spec-
trum of protonated tetracycline indicated that the dom-
inant loss of water was followed by elimination of
ammonia (Figure 11B). The fact that dehydration may
occur as the first step for protonated tetracycline but
loss of ammonia occurs as the favored first step for the
sodium complex underscores the striking difference in
the favored fragmentation pathways of the different
precursor ions, despite the superficial similarities in the
loss of small neutrals. The absence of lower mass
fragment ions in the CAD spectrum of the sodium
complexes suggests that the loss of ammonia is so
Figure 10. CAD of (tetracycline1Co2112CH3CN) complex.
Figure 11. Photodissociation spectra of (A) (L1Na1) complex
and (B) protonated tetracycline.
Table 2. CAD and IRMPD spectra of tetracycline complexes:
Percentage fragment distribution
Fragment CAD IRMPD
(Tetracycline1Mg211
2CH3OH)
2NH3 15 1
2H2O 60 5
2CH3OH 0 3
2CH3OH, 2H2O 25 29
22CH3OH 0 28
22CH3OH, 2H2O 0 23
22CH3OH, 2H2O, 2NH3 0 3
461 0 8
(Tetracycline1Ca2112CH3OH)
2NH3 2 0
2H2O 10 5
2CH3OH 25 30
2CH3OH, 2H2O 48 23
22CH3OH 10 14
22CH3OH, 2H2O 5 10
22CH3OH, 2H2O, 2NH3 0 3
1541 0 5
1261 0 3
981 0 5
581 0 2
(Tetracycline1Co2112CH3CN)
2NH3 10 5
2H2O 72 30
2H2O, 2NH3 18 24
2CH3CN, 2H2O 0 15
2CH3CN, 2H2O, 2NH3 0 8
22CH3CN, 2H2O 0 5
1541 0 4
1261 0 3
981 0 4
581 0 2
(Tetracycline1Na1)
2H2O 0 0
2NH3 70 14
2NH3, 2H2O 30 28
4101 0 5
3871 0 25
1931 0 15
1761 0 5
1541 0 3
581 0 5
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kinetically favored that the complex cannot accumulate
sufficient internal energy to access other fragmentation
channels prior to decomposition, unlike the CAD of
protonated tetracycline in which the characteristic frag-
ment ions at m/z 154 and 98 were observed. The
photodissociation spectrum of the sodium complex, in
contrast, is much richer than the CAD spectrum and
shows other fragment ions in the low to mid mass range
that provide a useful pattern for identification. The
formation of the ion at m/z 410 suggests the consecu-
tive losses of NaOH and NH3. The fragments at m/z
193 and 176 correspond to fragment ions observed in
the photodissociation spectrum of protonated tetracy-
cline and shifted upwards by the mass of sodium. The
richness of the photodissociation spectrum is attributed
to the ongoing photoabsorption and dissociation of
primary fragment ions during the nonselective photo-
activation process.
The CAD spectrum of the (tetracycline1Mg211
2CH3OH) complex predominantly undergoes dehydra-
tion or dehydration in conjunction with a loss of one
unit of methanol. The absence of other fragment ions
makes the diagnostic utility of this fragmentation pat-
tern low. However, it is interesting to note that the loss
of water from the tetracycline molecules is more facile
than elimination of one solvent molecule from the Mg21
ion. This result indicates that the solvent molecules are
strongly coordinated to the metal ion. The photodisso-
ciation spectrum shows a much more extensive series of
losses of water, ammonia, and solvent molecules from
the (tetracycline1Mg2112CH3OH) complex. In this
case, both units of methanol may be shed, and the losses
of ammonia and water are equally competitive with
desolvation of the metal ion. In most respects, the CAD
and PD fragmentation patterns of the (tetracycline1
Ca2112CH3OH) ions are qualitatively similar to those
of the (tetracycline1Mg2112CH3OH) ions. The com-
plex undergoes loss of solvent molecules, water and
ammonia, either consecutively or individually, and all
processes appear to be kinetically competitive. Frag-
ment ions at m/z 58, 98, 126, and 154 are characteristic
of the tetracycline skeleton and are the same ions
observed upon CAD or IRMPD of protonated tetracy-
cline.
The fragmentation patterns of the (tetracycline1
Co2112CH3CN) complexes are generally similar to
those of the alkaline earth complexes, but the solvent
molecules appear to be more strongly bound to the
Co21 than they were to the alkaline earth ions because
they are less easily shed upon activation of the solvated
complex. For example, low energy CAD of the
(tetracycline1Co2112CH3CN) complex indicates that
the lowest energy dissociation pathway is dehydration,
not elimination of a solvent molecule (Figure 10). How-
ever, the photodissociation spectrum shows that water,
ammonia, and acetonitrile units can be eliminated if the
ions are sufficiently energized (Figure 9A, B). In addi-
tion, minor amounts of low mass fragment ions at m/z
154, 126, 98, 86, and 58 are observed in the photodis-
sociation spectrum, and these fragment ions are identi-
cal to those seen in the photodissociation spectrum of
protonated tetracycline. These fragment ions clearly do
not contain the metal.
In summary, the fragmentation patterns of the metal
complexes afford little additional structurally diagnos-
tic information when compared to that obtained from
the protonated molecules. Although the photodissocia-
tion spectra appear richer, many of the fragment ions
are attributed to losses of the solvent molecules in
conjunction with the ubiquitous losses of ammonia
and/or water. Moreover, the low mass and mid mass
regions of the spectra are relatively devoid of diagnostic
fingerprint ions. Perhaps the most striking feature of the
metal complexes is that the solvent molecules are quite
strongly bound to the metal ion, such that the solvent
molecules are not automatically shed during activation
of the complexes. In addition, the photodissociation
spectra exhibit a richer array of fragments than ob-
served by conventional collisional activation, and this
result is attributed to the ongoing photoactivation of
primary fragment ions that leads to new secondary
fragment ions, and the ability to effectively trap a wider
mass range of ions because of the independence of the
photoactivation process from the radiofrequency stor-
age level. Moreover, the lower mass ions observed in
the IRMPD spectra do not incorporate the metal, thus
leading to fragment ions that are identical to ones seen
in the CAD spectra of protonated tetracycline.
Metal Binding Selectivity of Tetracycline
To compare the metal binding preferences of the tetra-
cycline compounds, selectivity experiments were un-
dertaken in which two or more metals were added of
the same concentration (always at least twice that of the
tetracycline) to a solution containing tetracycline. In
these preliminary experiments, tetracycline showed a
greater preference for binding magnesium over calcium
over cobalt over nickel and copper. On a relative scale,
the binding selectivity was estimated to be roughly
10:3:2:1:1 for Mg21:Ca21:Co21:Cu21:Ni21. These mea-
surements were undertaken for acetonitrile solutions,
and future studies will be directed toward examining
the binding selectivities in aqueous solutions at various
ranges of pH values. In addition, the tetracyclines
showed the lowest binding selectivities for the alkali
metal ions, an unsurprising result because of the lower
charge of the alkali metals. The relative order estab-
lished above cannot be directly compared to the known
binding constants reported for tetracyclines in aqueous
solutions because of the different solution environ-
ments and the tendency for 2:1 complex formation in
aqueous solutions.
Conclusions
The tetracyclines are amenable to analysis and identifi-
cation by ESI with photodissociation as an alternative to
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conventional CAD. The photodissociation spectra pro-
vide a more extensive array of fragment ions, including
key diagnostic low mass ions that are frequently not
observed upon CAD because of the limited low mass
storage range used during the collisional activation
period. Nearly all of the tetracycline derivatives disso-
ciate by common pathways (i.e., formation of m/z 58,
98, 126, 154), thus these fragmentation patterns are
more useful for identifying the class of compounds
rather than the specific derivative. Complexation with
metal ions provides a reasonably efficient alternative to
conventional protonation, and the doubly charged
metal ions remain solvated by two or three solvent
molecules throughout the complexation process. The
solvent molecules are so strongly bound that they may
remain attached to the metal ion during CAD or PD of
the tetracycline complexes. The metal complexes disso-
ciate by pathways that were also noted for fragmenta-
tion of the protonated molecules (i.e., dehydration,
deamination), and thus additional diagnostic structural
information is not obtained from the metal complexes.
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